11.07.2015 Views

Transforming and Supporting Patient Care - Health Professions ...

Transforming and Supporting Patient Care - Health Professions ...

Transforming and Supporting Patient Care - Health Professions ...

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

169Chapter 7 – <strong>Professions</strong> of Chiropody <strong>and</strong> Podiatry3. Include new drugs in current drug regulation; <strong>and</strong>4. Order laboratory tests.Preparing for New AuthoritiesThe CCO <strong>and</strong> the professions recognize the risk of harm associated withadministering substances by inhalation. That risk of harm would bemitigated by authorizing only those registrants who demonstrate therequisite competencies to perform that component of the controlled actsafely <strong>and</strong> effectively. A st<strong>and</strong>ard of practice would specify clearly thecircumstances <strong>and</strong> conditions under which inhalation could be used <strong>and</strong>how the substances would be maintained <strong>and</strong> secured, backed up by theCCO’s quality assurance program.The risk of harm associated with inhalation, in the view of the CCO <strong>and</strong> theprofessions, is more than offset by the risk of harm in not being able to useinhalants when responding to emergencies that may occur when performingsurgical procedures in non-institutional settings <strong>and</strong> by the enhanced abilityto manage patient pain <strong>and</strong> stress. A CCO st<strong>and</strong>ard of practice <strong>and</strong> qualityassurance program will ensure that registrants are able to perform suchprocedures safely <strong>and</strong> effectively <strong>and</strong> that the substances involved aresafely <strong>and</strong> securely stored <strong>and</strong> maintained. 16The profession received approval of its drug regulation in September 2008,<strong>and</strong> as a result the CCO is currently developing st<strong>and</strong>ards of practice,guidelines, continuing education <strong>and</strong> quality assurance requirements forthe prescribing <strong>and</strong> administration of drugs, <strong>and</strong> expects to have themcompleted <strong>and</strong> in force by late 2009. 17In its written submission to HPRAC, the CCO explained that in order toensure that each chiropodist is competent to prescribe the drugs listed inthe new regulation safely <strong>and</strong> effectively, it is presently undertaking aregistrant-by-registrant investigation of competencies. The CCO’sinvestigation relies heavily on the pharmacotherapy education received aspart of each registrant’s diploma program <strong>and</strong> any subsequent post-graduateor continuing education programs successfully completed thereafter. Terms,conditions <strong>and</strong> limitations applying to prescribing will be attached to eachregistration, unless <strong>and</strong> until that registrant demonstrates full competenciesto the CCO’s satisfaction. The same process will be applied to anyexp<strong>and</strong>ed authorities awarded to the profession. 18Until the assessment is completed, the CCO is uncertain of the number ofchiropody-trained members who may need a bridging program to becomeready for the authority to prescribe or administer drugs.The CCO stated in its written submission that those relatively recentgraduates of DPM programs who are practising in Ontario as chiropodists,16CCO, OPMA <strong>and</strong> OSC. Joint submission to HPRAC: Review of Non-Physician Prescribing: 21.17Ibid 22, 26-27.18Ibid. 23HPRAC Critical Links January 2009

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!